Article

The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2

medRxiv · 2020 · James Zhu, author Jiwoong Kim, author Xue Xiao, author Yunguan Wang, author Danni Luo, author Shuang Jiang, author Ran Chen, author Lin Xu, author He Zhang, author Lenny Moise, author Andres H. Gutierrez, author Anne S. De Groot, author Guanghua Xiao, author John W. Schoggins, author Xiaowei Zhan, author Tao Wang, author Yang Xie, author

Key facts

Title The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2
First author James Zhu, author Jiwoong Kim, author Xue Xiao, author Yunguan Wang, author Danni Luo, author Shuang Jiang, author Ran Chen, author Lin Xu, author He Zhang, author Lenny Moise, author Andres H. Gutierrez, author Anne S. De Groot, author Guanghua Xiao, author John W. Schoggins, author Xiaowei Zhan, author Tao Wang, author Yang Xie, author
Journal medRxiv
Published Sep 4, 2020
DOI 10.1101/2020.02.08.939553
Devices mentioned 019843

At a glance

  • 1–9 FDA submissions mentioned
  • None Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature